Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Physician and his practice to pay $6.7M for allegedly performing unnecessary vascular procedures
The physician was accused of pressuring Medicare patients into undergoing treatment they did not need. One patient allegedly received 42 different stents over an eight-year period.
Heart experts concerned after Trump administration authorizes fruit-flavored e-cigarettes
This is the first time the FDA has authorized market access for non-tobacco, non-menthol electronic nicotine delivery systems.
FDA adds surgical sponges, strips to list of shortages after Medline recall
Regulators said the shortages of neurosurgery devices are likely to extend until the end of the year. Medline recalled its neurosurgical patties due to a potential toxicity issue. The FDA said it's looking for alternatives.
Cannabis use increases risk of death, heart attack for ED patients
When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.
Resilia tissue developed by Edwards Lifesciences associated with long-term durability
Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.

IV fluids recalled over possible contamination—patients face risk of vascular complications

Particulate matter may be present in certain 1-liter containers of B. Braun Medical's Lactated Ringer's Injections. If this enters a patient's circulatory system, it could lead to a series of adverse events.

FDA warns public about vascular device after 3 deaths

The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.

Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform

Ultreon 3.0 was built to capture and evaluate OCT images, providing real-time guidance during complex PCI procedures.

The Society for Cardiovascular Angiography and Interventions (SCAI) is entering a new chapter as Dawn Abbott, MD, MSCAI, who assumeed the presidency this week with a focus on strengthening the future of interventional cardiology through workforce development, expanded training pathways and continued efforts to broaden inclusion in the specialty. #SCAI2026 #SCAI26

New SCAI President Dawn Abbott outlines workforce training and inclusion priorities

SCAI President Dawn Abbott, MD, MSCAI, aims to turn attention toward the long-term sustainability of the interventional cardiology field.

FDA recall medical device recall product recall

Boston Scientific pacemakers recalled again—software update now available

The new Class I recall, which includes more than 1.4 million devices, is related to an issue first announced back in 2024. Updating the software should address the issue going forward, though some patients may still require an early replacement.

Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B

Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI

Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

Multiple GLP-1 drugs linked to lower AFib risk

The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.

survey polling quick data check mark poll research doctor

Current political climate having 'detrimental' effect on radiology research, survey says

Published in Clinical Imaging, the responses indicate that Trump administration policies have made it more difficult to acquire funding and collaborate with other researchers.

Clinical

Physician and his practice to pay $6.7M for allegedly performing unnecessary vascular procedures

Heart experts concerned after Trump administration authorizes fruit-flavored e-cigarettes

FDA adds surgical sponges, strips to list of shortages after Medline recall

Cannabis use increases risk of death, heart attack for ED patients

Resilia tissue developed by Edwards Lifesciences associated with long-term durability